Additionally, it acts as a tyrosine kinase inhibitor targeting VEGFR1, VEGFR2, VEGFR3, PDGFRβ, ret proto-oncogene (RET), and fms-related tyrosine kinase 3, resulting in the inhibition of tumor proliferation [222]. This evidence concerns the gene FLT1 and neoplasm.